448 related articles for article (PubMed ID: 24920801)
1. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.
Cormier SA; Shrestha B; Saravia J; Lee GI; Shen L; DeVincenzo JP; Kim YI; You D
J Virol; 2014 Aug; 88(16):9350-60. PubMed ID: 24920801
[TBL] [Abstract][Full Text] [Related]
2. IL-4Rα on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection.
Shrestha B; You D; Saravia J; Siefker DT; Jaligama S; Lee GI; Sallam AA; Harding JN; Cormier SA
J Leukoc Biol; 2017 Jul; 102(1):153-161. PubMed ID: 28389622
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.
Ripple MJ; You D; Honnegowda S; Giaimo JD; Sewell AB; Becnel DM; Cormier SA
J Immunol; 2010 Oct; 185(8):4804-11. PubMed ID: 20861354
[TBL] [Abstract][Full Text] [Related]
4. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.
Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE
J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215
[TBL] [Abstract][Full Text] [Related]
6. IL-4Rα on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates.
You D; Marr N; Saravia J; Shrestha B; Lee GI; Turvey SE; Brombacher F; Herbert DR; Cormier SA
J Leukoc Biol; 2013 Jun; 93(6):933-42. PubMed ID: 23543769
[TBL] [Abstract][Full Text] [Related]
7. Effect of respiratory syncytial virus infection on plasmacytoid dendritic cell regulation of allergic airway inflammation.
Tsuchida T; Matsuse H; Fukahori S; Kawano T; Tomari S; Fukushima C; Kohno S
Int Arch Allergy Immunol; 2012; 157(1):21-30. PubMed ID: 21894025
[TBL] [Abstract][Full Text] [Related]
8. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease.
You D; Siefker DT; Shrestha B; Saravia J; Cormier SA
Respir Res; 2015 Aug; 16(1):91. PubMed ID: 26231396
[TBL] [Abstract][Full Text] [Related]
9. Natural helper cells are associated with the exacerbated airway inflammation seen during RSV reinfection of neonatally primed mice.
Wu J; Hu H; Xu L; Qi F; Bai S; Cui Y; Chai R; Wang D; Liu B
Int Immunopharmacol; 2017 Apr; 45():156-162. PubMed ID: 28219838
[TBL] [Abstract][Full Text] [Related]
10. Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.
Harker JA; Lee DC; Yamaguchi Y; Wang B; Bukreyev A; Collins PL; Tregoning JS; Openshaw PJ
J Virol; 2010 May; 84(10):5294-302. PubMed ID: 20200251
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
[TBL] [Abstract][Full Text] [Related]
12. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
[TBL] [Abstract][Full Text] [Related]
13. Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.
Schuurhof A; Bont L; Pennings JL; Hodemaekers HM; Wester PW; Buisman A; de Rond LC; Widjojoatmodjo MN; Luytjes W; Kimpen JL; Janssen R
J Virol; 2010 Sep; 84(18):9584-94. PubMed ID: 20592085
[TBL] [Abstract][Full Text] [Related]
14. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
[TBL] [Abstract][Full Text] [Related]
15. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
Johnson TR; Mertz SE; Gitiban N; Hammond S; Legallo R; Durbin RK; Durbin JE
J Immunol; 2005 Jun; 174(11):7234-41. PubMed ID: 15905569
[TBL] [Abstract][Full Text] [Related]
16. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
Front Immunol; 2020; 11():1673. PubMed ID: 32849580
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
Dakhama A; Lee YM; Ohnishi H; Jing X; Balhorn A; Takeda K; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):138-145.e5. PubMed ID: 19056111
[TBL] [Abstract][Full Text] [Related]
18. A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.
Lindell DM; Morris SB; White MP; Kallal LE; Lundy PK; Hamouda T; Baker JR; Lukacs NW
PLoS One; 2011; 6(7):e21823. PubMed ID: 21789184
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
Schijf MA; Lukens MV; Kruijsen D; van Uden NO; Garssen J; Coenjaerts FE; Van't Land B; van Bleek GM
PLoS One; 2013; 8(11):e81695. PubMed ID: 24303065
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.
Monick MM; Powers LS; Hassan I; Groskreutz D; Yarovinsky TO; Barrett CW; Castilow EM; Tifrea D; Varga SM; Hunninghake GW
J Immunol; 2007 Aug; 179(3):1648-58. PubMed ID: 17641031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
